Clinical Infectious Diseases · 2020 · 32 citations · 26 references
Veterinary MedicineChild HealthInfectious DiseasesEpidemiologyInfectious Disease EpidemiologyPediatric Infectious DiseasesChild Health EpidemiologyRespiratory DiseaseRespiratory Disease Epidemiology In ChildrenRespiratory Infectious DiseasesSeroprevalence StudiesViral EpidemiologyCross-sectional Incidence StudyCross-sectional SeroprevalenceSars-cov-2 InfectionSevere Acute Respiratory Syndrome
BACKGROUND: Susceptibility of children and adults to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and persistence of antibody response to the virus after infection resolution remain poorly understood, despite their significant public health implications. METHODS: A prospective cross-sectional seroprevalence study with volunteer families that included at least 1 first-reported adult case positive by SARS-CoV-2 by polymerase chain reaction (PCR) and at least 1 child aged <15 years living in the same household under strict home confinement was conducted in the metropolitan Barcelona Health Region, Spain, during the pandemic period 28 April 2020-3 June 2020. All household members were tested at home using a rapid SARS-CoV-2 antibody assay with finger prick-obtained capillary blood. RESULTS: A total of 381 family households including 381 first-reported PCR-positive adult cases and 1084 contacts (672 children, 412 adults) were enrolled. SARS-CoV-2 seroprevalence rates were 17.6% (118 of 672) in children and 18.7% (77 of 335) in adult contacts (P = .64). Among first-reported cases, seropositivity rates varied from 84.0% in adults previously hospitalized and tested within 6 weeks since the first positive PCR result to 31.5% in those not hospitalized and tested after that lag time (P < .001). Nearly all (99.9%) positive children were asymptomatic or had mild symptoms. CONCLUSIONS: Children appear to have similar probability as adults to become infected by SARS-CoV-2 in quarantined family households but remain largely asymptomatic. Adult antibody protection against SARS-CoV-2 seems to be weak beyond 6 weeks post-infection confirmation, especially in cases that have experienced mild disease.
26
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Clinical Characteristics of Coronavirus Disease 2019 in China
Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
Stephen A. Lauer, Kyra H. Grantz, Qifang Bi et al. · Annals of Internal Medicine · 2020 · 6.6K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
Epidemiology of COVID-19 Among Children in China
Yuanyuan Dong, Xi Mo, Yabin Hu et al. · PEDIATRICS · 2020 · 4.3K citations · Full text